Viewing Study NCT04418167


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2025-12-26 @ 1:39 PM
Study NCT ID: NCT04418167
Status: SUSPENDED
Last Update Posted: 2025-09-03
First Post: 2020-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Sponsor: JS InnoPharm, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-18
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2020-05-11
First Submit QC Date: None
Study First Post Date: 2020-06-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-26
Last Update Post Date: 2025-09-03
Last Update Post Date Type: ESTIMATED